| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46c4c0a382af630b87d1cd210ac7f183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdf93e9ef6460fe2dd83a85afff348bb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
| filingDate |
2006-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c01ab871e98f451714322b29b80182c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0edab82c1508729a15902821238b396 |
| publicationDate |
2007-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007197663-A1 |
| titleOfInvention |
Methods of treating memory and cognitive impairments in humans following stroke and traumatic brain injury |
| abstract |
Cognitive impairments are treated and cognition is improved with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010137639-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9380976-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9085510-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013191724-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009197969-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010249242-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010065387-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011105621-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9265458-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9040082-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8461381-B2 |
| priorityDate |
2000-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |